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Abstract
Engineering novel allostery into existing proteins is a challenging endeavor to obtain novel sensors, therapeutic proteins, or
modulate metabolic and cellular processes. The RG13 protein achieves such allostery by inserting a circularly permuted
TEM-1 b-lactamase gene into the maltose binding protein (MBP). RG13 is positively regulated by maltose yet is,
serendipitously, inhibited by Zn
2+ at low mM concentration. To probe the structure and allostery of RG13, we crystallized
RG13 in the presence of mM Zn
2+ concentration and determined its structure. The structure reveals that the MBP and TEM-1
domains are in close proximity connected via two linkers and a zinc ion bridging both domains. By bridging both TEM-1 and
MBP, Zn
2+ acts to ‘‘twist tie’’ the linkers thereby partially dislodging a linker between the two domains from its original
catalytically productive position in TEM-1. This linker 1 contains residues normally part of the TEM-1 active site including the
critical b3 and b4 strands important for activity. Mutagenesis of residues comprising the crystallographically observed Zn
2+
site only slightly affected Zn
2+ inhibition 2- to 4-fold. Combined with previous mutagenesis results we therefore hypothesize
the presence of two or more inter-domain mutually exclusive inhibitory Zn
2+ sites. Mutagenesis and molecular modeling of
an intact TEM-1 domain near MBP within the RG13 framework indicated a close surface proximity of the two domains with
maltose switching being critically dependent on MBP linker anchoring residues and linker length. Structural analysis
indicated that the linker attachment sites on MBP are at a site that, upon maltose binding, harbors both the largest local Ca
distance changes and displays surface curvature changes, from concave to relatively flat becoming thus less sterically
intrusive. Maltose activation and zinc inhibition of RG13 are hypothesized to have opposite effects on productive relaxation
of the TEM-1 b3 linker region via steric and/or linker juxtapositioning mechanisms.
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Introduction
Allosteric regulation is a common mechanism cells utilize to
regulate protein activity. Heterotropic allosteric proteins have
a ligand binding site distant from the substrate binding site to allow
conformational changes to be transmitted from the ligand
regulatory binding site. As such, engineered proteins with allosteric
properties have attractive applications including molecular
biosensors, therapeutic proteins, and gene regulation [1,2]. One
approach to engineering allosteric proteins is to mimic non-
homologous recombination via domain/module combinations and
rearrangements. This approach can develop complex new
functions involving molecular recognition and regulation [3] and
can lead to development of analytical molecular sensors [4]. A
successful example of this approach is the allosteric protein RG13
which is a molecular switch created by recombining the non-
homologous genes encoding MBP and TEM-1 b-lactamase and
subjecting the resulting library to evolutionary pressure [5]. In
brief, a circular permutated TEM-1 gene was randomly inserted
into the gene encoding MBP. The constructs were subjected to an
in vivo selection for high ampicillin hydrolysis activity in the
presence of maltose, followed by an in vitro screen for variants with
maltose-dependent rate of b-lactam hydrolysis. The resulting
RG13 construct was demonstrated, in the presence of maltose, to
have b-lactamase activity comparable to the wild-type TEM-1 b-
lactamase but RG13’s activity (kcat/Km) decreased 25-fold in the
absence of maltose [5]. As a consequence, the RG13 gene confers
a maltose-dependent ampicillin resistance to E. coli cells [5].
Intriguingly, RG13 activity was serendipitously found to be
negatively regulated by Zn
2+ at low mM concentrations in a non-
competitive and reversible mode, a characteristic that neither
parent protein MBP nor TEM-1 possesses [6].
The primary structure of RG13 is unusual in that it is a 72kD
fusion protein of TEM-1 inserted into MBP [5]. Due to the
circularly permutated TEM-1 gene, the new TEM-1 N-terminal
residue 229 is inserted after MBP residue 316 whereas the new
C-terminal residue of TEM-1, residue 228, is connected to MBP
residue 319 via an extra serine residue [5]. The original N- and
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39168C-terminal residues of TEM-1 are connected via a linker
GSGGG. In total, there are two connections between the
TEM-1 and MBP domains in RG13 (Figure 1A).
To our knowledge, the structural basis for how allostery is
achieved by non-homologous domain insertion has not been
described. Initial insights into the allosteric mechanism of RG13
were obtained by the Ostermeier lab with mutational studies
indicating that the extent of the domain closure angle in the MBP
domain, which is maximally achieved by maltose binding, is
responsible for affecting TEM-1 activity in RG13 [5,7]. A recent
NMR study compared the NMR data of RG13 in the absence/
presence of maltose with data from previous NMR studies of MBP
and TEM-1 and provided evidence that: (1) the individual MBP
and TEM-1 domain structures in RG13 are substantially
conserved; (2) the TEM-1 active site of RG13 is relatively
unperturbed in the presence of maltose; and (3) in the absence of
maltose the active site of RG13 is slightly perturbed with possible
displacement of several residues [8]. Less is known about the
negative allosteric regulation of RG13 by Zn
2+. Previous
mutagenesis studies involving single and double mutations have
potentially ruled out all Cys and His residues for Zn
2+ binding [6]
but did suggest a possible role for TEM-1 residues H26 and H289
in the zinc inhibition mechanism. Upon mutating both of these
residues to alanine, the Zn
2+ Ki increased 30-fold although
a corresponding loss of Zn
2+ affinity was not observed [6].
We are interested in further delineating the mechanism of
switching of RG13 as to how the TEM-1 activity is positively
regulated by the allosteric effector maltose and negatively
regulated by Zn
2+. The RG13 crystal structure with mM Zn
2+
concentration in the crystal presented here shows RG13 with
a distorted TEM-1 domain with a zinc ion bound at an inter-
domain site. The structure shows that this zinc ion bridges the
TEM-1 and MBP at an additional contact point away from the
linker region between the two domains thereby negatively affecting
the conformation of this linker region. An analogous distortion of
this linker may be key for RG13’s compromised catalytic activity
in the absence of maltose. To gain additional insights, we carried
out mutagenesis studies to probe both the linker region and the
zinc site as well as carried out molecular modeling to investigate
RG13 with an intact TEM-1 domain.
Results
Overall Structure
Two types of crystals of RG13 were grown in the presence of
high zinc concentration (2.5 mM). These crystals belonged to
space groups P1 and C2 and were refined to 2.30 and 2.29A ˚
resolution, respectively (Table 1). The structure reveals that despite
the domain shuffling, circular permutation, and different connec-
tions, RG13 contains two folded domains comprised of the
regulatory MBP and the catalytic TEM-1 (Figure 1B). The overall
dimensions of each RG13 molecule are roughly 50670670A ˚ with
the TEM-1 and MBP domains lying alongside each other
connected by two linkers. The two RG13 molecules in the P1
space group have a similar conformation as the root-mean-square-
deviation (r.m.s.d.) for Ca atoms is 0.39A ˚ (for 636 residues).
Superpositioning of the RG13 molecule from the C2 space group
onto each of two molecules in the P1 space group yields r.m.s.d.’s
of 1.7 A ˚ (619 residues) and 1.6 A ˚ (615 residues) for molecules A
and B, respectively. The electron density for most of RG13 is well
resolved including most, but not all, of the TEM-1 active site
(Figure S1). The two connecting loops between TEM-1 and MBP
could only be resolved in the P1 space group (in both monomers)
(Figure S1) although these loops, not unexpectedly, have higher
Figure 1. Overall structure of RG13. (A) RG13 primary structure. (B) Schematic diagram of RG13 crystal structure with zinc ions bound. TEM-1 and
MBP domains are colored magenta and yellow, respectively. Zinc ions are shown as grey spheres and the engineered GSGGG linker is colored cyan.
To indicate the position of the TEM-1 active, its catalytic serine residue is highlighted in spheres. The linker 1 and linker 2 regions between the MBP
and TEM-1 subdomains are labeled as ‘19 and ‘29, respectively; (C) Superposition of the two RG13 crystal forms of the TEM-1 domain reveals a slightly
different orientation of the MBP domain after TEM-1 domain superpositioning.
doi:10.1371/journal.pone.0039168.g001
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part of these linker regions comprising residues 317–327 and 583–
584 are not included in the C2 space group structure due to lack of
electron density. Similarly, the GSGGG linker introduced to
circularly permute TEM-1 is resolved in the electron density maps
but also has somewhat higher temperature factors compared to the
cores of the two domains (Figure S1).
The orientation between RG13’s TEM-1 and MBP domains in
the C2 space group is somewhat different compared to that in the
P1 space group (Figure 1C). When superimposing the TEM-1
domains of the RG13 structures, the MBP domain orientation
between the two different space group structures is different by
about 8.5u: the MBP domain appears to pivot across the TEM-1
surface with MBP residues furthest from the TEM-1 domain
shifted more compared to the MBP residues closest to the TEM-1
domain likely a consequence of the bridging Zn
2+ and linkers
restrictions. These observed inter-domain orientational differences
indicate a degree of flexibility in orientation between the two
domains, not unexpectedly due to the presence of the somewhat
more mobile linker regions and the limited contacts between the
two domains. The additional Zn
2+ ion contact between MBP and
TEM-1 will be discussed next.
Zn
2+ Binding
In addition to the two RG13 monomers in the P1 space group,
there are four zinc ions present with two zinc ions bound per
monomer. Similarly, there are two zinc ions present in the C2
space group structure of RG13. The zinc ions are readily
identifiable being the strongest difference Fourier density features
in difference density maps (Figure S2). The Zn
2+ ions bound to the
three different RG13 monomers can be grouped in two different
classes: the main Zn
2+ ion, which bridges the TEM-1 and MBP
domains, and the non-interdomain bridging Zn
2+ ion. The main
Zn
2+ ion in the C2 RG13 structure bridges the TEM-1 and MBP
domains via residues H468 (H112, TEM-1 residue numbering
shown in italics and brackets from here on forward), residue E477
(E121), and both oxygens of residue D164 (MBP residue) (Figure
S2). In the P1 structure, residue E477 (E121) has slightly shifted
away and therefore the main Zn
2+ ion only interacts with H468
(H112) and both oxygens of D164 (Figure S2). The main Zn
2+ ion
binding site in RG13 is distant from the active site being 20A ˚ from
the Oc atom of the catalytic S426 (S70) residue. The (other) non
inter-domain bridging Zn
2+ ion makes liganding interactions with
residues H509 (H153) and H514 (H158) of the TEM-1 domain (in
C2 space group, Figure S2). A similar zinc binding site is also
present in the P1 space group involving the same H509 and H514
Table 1. Data collection and refinement statistics.
Data collection
space group P1 C2
cell dimensions
a, b, c (A ˚), a, b, c (deg)
48.32, 74.18, 103.13, 83.54, 77.64, 89.98 124.12, 47.78, 107.87, 90.00, 114.17, 90.00
wavelength (A ˚) 1.0810 1.0810
resolution (A ˚)
a 50.00–2.30 (2.38–2.30) 50.00–2.30 (2.38–2.30)
Rsym 5.4 (22.3) 5.1 (32.8)
I/sI 12.6 (3.8) 15.4 (2.7)
Completeness (%) 95.9 (95.5) 88.0 (88.2)
Redundancy 1.9 (1.9) 2.3 (2.3)
Refinement
Resolution range (A ˚) 31.45–2.29 (2.294–2.354) 42.32–2.30 (2.360–2.301)
no. of reflections 56130 22012
Rwork/Rfree 23.2/29.2 23.3/29.1
no. of atoms: protein, zinc ion, water 9851, 4, 490 4830, 2, 134
rmsd
b
bond length (A ˚) 0.007 0.006
bond angles (deg) 0.960 0.942
average B-factors (A ˚2)
Protein 34.385 41.047
zinc ion 31.573 40.825
Water 34.750 36.184
Ramanchandran plot statistics (%)
core regions 91.7 92.1
additional allowed regions 8.1 7.5
generously allowed regions 0.2 0.2
disallowed regions 0.0 0.2
aNumbers in parentheses refer to the highest resolution shell.
brmsd, root-mean-square deviation.
doi:10.1371/journal.pone.0039168.t001
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ligands from a crystallographically related RG13 MBP domain:
H399 and Y179 (Figure S2).
MBP Domain
MBP adopts a periplasmic binding fold and is capable of
undergoing a ligand-induced subdomain closure in which the
ligand maltose binds to both subdomain halves of MBP leading to
a domain closure of ,35u [9]. Superpositioning shows that the
MBP domain of RG13 conformation is more similar to the
uncomplexed MBP structure (PDB ID: 1OMP). The latter
superpositioning yielded relative low r.m.s.d. values of 1.25A ˚
monomer A in P1, 1.39A ˚ for monomer B in P1, and 1.81A ˚ in
space group C2 compared to superpositioning with the maltotriose
complexed MBP structure (PDB ID: 3MBP) which yielded larger
r.m.s.d.s. of 2.76 (P1 monA), 2.80 (P1 monB), and 2.0 A ˚ (C2) for
about 360 Ca atoms (Figure 2). This result is in agreement with
a subdomain rotation analysis indicating that RG13 is in a more
unliganded open conformation in both P1 and C2 spacegroups
since its domain closure angle is about 10u and 17u, respectively,
compared to that of the uncomplexed MBP structure (Figure 2).
The linker regions, where TEM-1 and MBP are fused, extend
from the backside of the MBP domain opposite of where maltose
binds. Therefore, the TEM-1 domain in RG13 will see a changing
surface upon maltose binding going from concave to more flat
(Figure 2B). This will have likely steric consequences for the linker
tension between the MBP and TEM-1 domains as will be
discussed later. The residues of the linkers closest to the MBP
domain that appear to be anchoring the linker to MBP are
residues S585 and R316 as the mainchain and sidechain residues
of these residues make numerous stabilizing interactions in the P1
space group (Figure 2C). Furthermore, S585 and R316 are also
the last residues visible in the C2 RG13 structure whereas the rest
of the linker regions are too disordered to be modeled in this C2
spacegroup.
TEM-1 Domain
TEM-1 is a b-lactamase that hydrolyses bicyclic b-lactam
compounds that contain a carboxyl moiety and a carbonyl
moiety. Key active site elements for TEM-1 are the catalytic S70,
the carboxyl binding pocket, the oxy-anion hole for carbonyl
oxygen, and the deacylation-water priming E166 residue. The
TEM-1 domain of RG13 has an overall fold similar to the wild-
type TEM-1 structure (PDB ID: 1ZG4) with r.m.s.d. values of
1.02A ˚ (P1 molA), 1.02 A ˚ (P1 molB), and 1.1 A ˚ (C2) for ,240 Ca
as calculated using COOT [10]. The most significant structural
change in the TEM-1 domain of RG13, compared to the wt
TEM-1 structure, is the displacement of TEM-1 residues 229–
244 which comprises the critical active site b3 strand, part of the
b4 strand, and the connecting loop between these strands. This
TEM-1 active site section in RG13 is now part of the linker 1
connecting the MBP and TEM domains (Figures 1B and 3). In
addition, the preceding residues 214–228 are in a somewhat
different conformation as the TEM-1 a10 helix extends in RG13
forming a longer helix (Figure 3). Despite these substantial active
site differences of missing active site b-strands, the positions of
most other active site TEM-1 residues including S70, Y105,
S130, N132, E166, and N170 (in TEM-1 residue numbering) are
relatively unchanged in RG13. The b3-strand plays an important
role for TEM-1 activity because it forms one of the active site
walls providing part of both the carboxyl binding pocket (via
S235) and oxy-anion hole for the carbonyl oxygen (via the
backbone nitrogen of residue A237) which are thus no longer in
the correct position in the Zn
2+ bound structure of RG13. b3-
strand residue K234 is also critical for b-lactamase functioning
[11] and is no longer in the native TEM-1 position (Figure 3).
Furthermore, b4-strand residue R244, which is also involved in
electrostatic interactions with the b-lactam carboxyl moiety [12],
has also shifted. This b3-b4-strand section, comprising TEM-1
residues 229–244 is in close proximity to one of the fusion sites,
i.e. residue 229, between TEM-1 and MBP (Figures 1 and 3) [5].
In addition to lacking some key active site features, the entry to
the TEM-1 active site in RG13 is partially blocked by this
displaced region that now forms a short helix (Figure 3). Taken
together, loss of b3-b4 strand section adopting a new conforma-
tion, now sterically blocking the active site, likely explains the
lack of activity of the Zn
2+-bound RG13 structure at mM
concentration of Zn
2+. Further away from the active site, residues
V216 and A217 have also shifted somewhat and these shifts
could also affect enzyme activity as those residues have been
shown to not tolerate changes [13]. However, this disturbance is
likely not a main contributor to the loss of activity.
Mutagenesis
To probe the importance of the crystallographically observed
main Zn
2+ binding site (Figure S2) for Zn
2+ inhibition of RG13,
we mutated the liganding residues D164, H468, and E477 to
alanine. In addition to the single mutants D164A and E477A, we
also constructed the D164A/H468A double mutant as well as the
D164A/H468A/E477A triple mutant. All proteins were purified
and confirmed to maintain their ability to be activated by maltose.
Both single mutants D164A and E477A were inhibited by Zn
2+ to
the same extent as wild-type RG13. The Ki for the D164A/H468A
double mutant was about 4-fold higher; however, the triple mutant
exhibited a Ki that was only 2-fold higher compared to RG13’s Ki
being (Table 2). The inhibition of all mutants fit well to a model of
a single Zn
2+-binding site. This data indicate that the D164A/
H468A/E477A site is not singly responsible for the mMZ n
2+
inhibition although some modest contribution to Zn
2+ inhibition
was observed.
To probe the importance of the linker 1 and linker 2 regions at
the site of fusion between TEM-1 and MBP, a set of point
mutations and single amino acid additions/deletions were
constructed (Figure 4A). Switching was measured as a ratio of
initial rates +/2 maltose at a particular concentration of substrate
that is around the Km (hence RG13 switching is not 25-fold).
Mutations to the linker 1 region either greatly diminished activity
(e.g. DW317) or resulted in a loss of switching. The effects of
mutations to the linker 2 varied from a loss of switching to a 2-fold
increase in switching (e.g. DG584). As a general rule, mutations
that caused an increased enzyme activity in the absence of maltose
also decreased switching (Figure 4B). Similarly, the DG584
mutation increased switching by decreasing the activity in the
absence of maltose. To test specifically potential MBP anchor
residues S585 and R316 (Figure 2B–2C) we mutated residues
S585 to an Ala (S585A) and separately deleted residue R316
(DR316); these mutants were found to have abrogated maltose-
switching. Overall, the linker 1 region could not tolerate any of the
three changes made to the linker without losing switching or
overall activity whereas 3 out of 5 linker 2 modifications still
yielded substantial switching activity. These results point to
a critical role for linker 1 in maltose switching likely due to being
adjacent to the key TEM-1 active site b3 strand section. In accord
with linker 1 and its anchoring residue(s) being critical in maltose
switching, loss of switching and restoration of maximal wt activity
in the absence of maltose can be achieved by increasing slack
immediately adjacent to the linker 1 anchor residue R316 via
insertion of a Gly residue (+G228) (Figure 4). Linker 2 is important
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observed upon altering the linker. As mentioned above, mutating
the anchor residue S585 to an Ala caused loss of switching.
Deleting either residue adjacent to S585 (i.e. G584 or A586) had
completely opposite effects on switching and points to an
important role for A586. Keeping the entire a15 anchoring
region intact (i.e. residues S585-A586) yet deleting G584 yielded
a hyper maltose switching variant (DG584). In contrast, deleting
the A586 residue, which makes key hydrophobic interactions and
is part of the a15 helix of MBP, eliminates the switching. This is
likely due to disruption of this S585-A586 a15 helix anchor region
as deletion of A586 will shift S585 to the position of this deleted
residue but this residue is likely unable to be accommodated due to
the serine’s larger size and more hydrophilic nature compared to
alanine. The significant switching activity still present for the
variant with the deletion of residue S585 is likely a consequence of
two opposite effects negating each other. The negative effect of
removing the anchoring abilities of residue S585, as observed for
the S585A mutation, is compensated for by the hyper-switching
effect of shortening the linker 2 region by the deletion as observed
for the DG584 mutant (while maintaining at least the A586 part of
the a15 helix anchor region). The insertion of a tryptophan in
the linker 2 region (+W229) still maintained some switching
activity but the structural consequences of increasing slack via
insertion of the largest hydrophobic amino acid are not easily
explained since this residue might generate additional (hydropho-
bic) anchoring interactions.
Figure 2. Structural analysis of the MBP subdomain angle variations. (A) Superposition of subdomain 1 of MBP reveals different domain
closure angles of subdomain 2. The superposed structures include uncomplexed MBP structure (PDB ID: 1OMP, grey), RG13 structure of P1 space
group (yellow), RG13 structure of C2 space group (wheat), and maltotriose complexed MBP structure (PDB ID: 3MBP, green). Subdomain 1 of MBP
with RG13 is defined by residues 1–109 and 261–316 and subdomain 2 is defined as 110–260 & 586–637. (B) Hypothesized surface change of MBP
upon maltose binding in the vicinity the fusion sites R316 and A586 (A319). The surface of the maltose-bound MBP (green) and uncomplexed
MBP domains (grey) are shown within the RG13 framework with TEM-1 depicted in a magenta Ca trace. The surface change from concave (grey
curved interrupted line) to flat (green straight interrupted line) going from uncomplexed to maltose-bound is indicated. (C) Close-up view of the
fusion site between MBP and TEM-1 showing the RG13 linker anchor residues R316 and S585 and their interactions with the rest of the MBP domain.
doi:10.1371/journal.pone.0039168.g002
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e39168Figure 3. Active site changes in TEM-1 domain of RG13 compared to wt TEM-1 structure. Superpositioning of wt TEM-1 structure onto the
TEM domain in RG13 reveals displacement of b3 strand and part of b4 strand (inset is a zoomed in view with secondary structure elements in
transparent representation). The TEM-1 b4 strand is mostly intact yet starts diverging at position R244. The a10 TEM-1 helix which is observed to be
more extended in RG13. Also labeled and underlined are the MBP helices a14 and a15 that form part of the linker anchor points in the RG13 fusion
protein. TEM-1 b3 strand residue positions K234, S235, A237, and b4 strand residue K244 are indicated as well as the new position of A237 with the
RG13 sequence A325. The zinc ion is indicated via a grey sphere.
doi:10.1371/journal.pone.0039168.g003
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2+ inhibition of TEM-1, RG13, and mutants thereof.
Protein kcat (s
21) Km (mM)
kcat/Km
(s
21mM
21) Ki for Zn
2+ (mM) Ref.
TEM-1 900 110 8.18 340–1100 [5,6]
RG13 200640 5506120 0.36 2.760.1, 3.260.5 [5,6], this study
RG13+maltose 620660 6864 9.12 2.160.2 [5,6]
RG13 D164A/H468A nd* Nd nd 8.761.4 this study
RG13 D164A/H468A/E477A nd Nd nd 4.161.0 this study
RG13 H375A/H382A nd Nd nd 7365 [6]
*nd, not determined; however, it was confirmed that all mutants were activated by maltose like RG13 using nitrocefin assays (100 mM nitrocefin) in the presence and
absence of maltose.
doi:10.1371/journal.pone.0039168.t002
Figure 4. The effect of mutations in linker 1 and linker 2 on maltose-induced switching. (A) Mutation locations and their effect on
switching. Residues derived from MBP are colored blue and those from TEM-1 are colored red. The corresponding numbers in the wt proteins are
indicated above. Mutations relative to RG13 are highlighted in yellow. The switching activity (fold increase in catalytic activity in the presence of
a saturating concentration of maltose) of each mutant is indicated on the right. Error bars are standard deviations (n$3). (B) Switching activity shown
as a function of enzyme activity in the absence of maltose. Mutations to linker 1 are shown in green and mutations to linker 2 are shown in red.
doi:10.1371/journal.pone.0039168.g004
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To gain insights into how an intact TEM-1 structure would fit
within the RG13 framework, we employed a rigid body modeling
approach. In short, this was done by modeling an intact TEM-1
molecule (with the b3-b4-strand section in the wild-type position)
in close proximity to the maltose-bound MBP within the RG13
framework (Figure 5). Firstly, maltotriose bound (PDB id: 3MBP)
and unbound (PDB id: 1OMP) MBP structures were superposed
onto the RG13-Zn
2+ crystal structure by superpositioning of
residues 1–109 and 261–316 which is one of the sub-domains of
MBP. The superposition indicated that the MBP anchor point
helices a14 and a15 move relative to each other upon maltose/
maltotriose binding (Figure 5A). Subsequently, G584 (G228) and
F318 (F230) were chosen as the modeling target points to attach
TEM-1 to the MBP in RG13 thereby keeping the R316/W317
and S585 MBP anchor regions intact (we kept W229 in its RG13
position)(Figure 5B). In the modeled TEM-MBP RG13-like
complex, the TEM-1 domain has a three dimensional location
fitting reasonably well only some van der Waals clashes as the two
domains are in very close proximity (Figure 5C). Nevertheless, in
the modeled complex, the TEM-1 G228 modeling target point is
in closer proximity to F318 compared to where it is in the RG13-
Zn structure, being RG13 residue G584 (Figure 5B). As noted
above, this target attachment point G584 is however anticipated to
shift in closer proximity upon maltose binding based upon
superpositioning of the maltose-free and maltose/maltotriose-
bound MBP (Figure 5A). Thus, the movement extrapolated to
occur upon maltose binding (Figure 5A) and the movement
needed to occur to have residues G584 (228) and F318 (230)i nw t
TEM-1 proximity (Figure 5B) are in roughly the same direction
suggesting that maltose binding could juxtaposition TEM-1
residues G228 and F230 to a shorter more native like distance.
This shift is likely key as residue G228 is the start of the important
active site b3 strand. Therefore, we propose that maltose binding
likely tweaks this RG13 region such that the b3-b4 strand region
involving TEM-1 residues 228–244 is relaxed enough to fit
correctly and productively in the active site such that RG13 yields
wild-type TEM-1 activity in the presence of maltose. Concomi-
tantly, the local surface change from concave to flat near the linker
attachments points on MBP upon maltose binding (Figure 2B) will
likely result in less steric clashes between the two domains and also
less pull on the TEM-1 b3 strand.
Discussion
The crystal structure of RG13 bound to the non-competitive
Zn
2+ inhibitor provides insights into the heterotropic allosteric
signaling of RG13 although the relative importance of the inter-
domain Zn
2+ site is not immediately evident. The structure reveals
that the TEM-1 and MBP domains are in close proximity to each
other connected via two linkers and a bridging Zn
2+ ion
(Figure 1B). Whereas the MBP domain is quite intact adopting
a relatively open/unliganded conformation, the TEM-1 domain
active site is compromised with the active site b3-b4 strand section
mostly displaced from its wild-type TEM-1 position with this
displaced section now partially blocking substrate entry while also
forming a linker between the two domains (Figure 3). Comparison
of two different space group RG13 structures reveals that there is
still some flexibility in the orientation between the MBP and
TEM-1 domains as well as within the two lobes of MBP (Figure 1C
and 2A). The zinc ion at high mM concentration therefore seems
to inhibit RG13 by generating an additional anchor point between
the two domains and therefore acts to ‘twist-tie’ the original
anchor points and linkers such that these linkers are contorted and
no longer have enough slack to be inserted productively into the
active site (in particular b3-b4 strand residues 226–244). The b-
strand expulsion and re-insertion is reminiscent of how the
bloodclotting serpin anti-thrombin is regulated [14,15]. The zinc
ion observed at the inter-domain site acts thus as a non-
competitive inhibitor binding distant from the active site yet
clearly affecting b-lactamase activity. Before discussing the relative
importance of the Zn
2+ site, we will first describe the structural
consistencies of the RG13 structure with the currently available
data.
Structural Agreement with Non-Crystallographic Data
Many crystallographically observed details of the RG13
structure correlate well with previously published data on RG13
(in the presence or absence of maltose) or are in agreement with
mutagenesis data presented herein: (1) the position of the small
TEM-1 a11 helix comprising residues 220–225 is perturbed
compared to wt TEM-1 (Figure 6) in agreement with NMR data
that pointed to a different position for this region in both the
absence and presence of maltose [8]. This is not too surprising
since MBP is fused to TEM-1 at nearby position 228. (2) The
original C-terminal helix of TEM-1, a12, is somewhat shifted
(Figure 6) as was also observed by NMR [8]. A possible
explanation for this a12 shift is the shift of the flanking a11 helix
and possibly the presence of the new GSGGG linker. (3) The
RG13 structure contains an inhibitory inter-domain Zn
2+ site that
forces RG13 to adopt a conformation that provides a b3-strand
involving mechanism regarding explaining the non-competitive
inhibitory properties of Zn
2+ [6], although the observed Zn
2+ site
is likely not singly responsible for the entire inhibitory effect (as will
be discussed below). (4) MBP is observed in a mostly open/
unliganded conformation since no maltose was included during
the crystallization. (5) Most, but not all, of the TEM-1 active site
residues are in unperturbed positions as also observed using NMR
[8]. (6) The structure pointed to important structural roles for the
linker anchor residues S585 and R164 as also determined by
mutagenesis. (7) The N-terminal section of the TEM-1 b3 strand
region adjacent to the 229 fusion site was previously pinpointed by
NMR as potentially mechanistically important; this section was
observed by NMR to be displaced in the absence of maltose [8].
The RG13 structure shows also a displacement of this section,
albeit more drastic as the entire b3 strand is displaced. Neverthe-
less, both independent observations are consistent and point to
a crucial role for part or the whole b3 strand which is adjacent to
the 229 fusion site.
Insights into a Maltose-Activated RG13 Structure
From the above analyses it is evident that RG13 if it has Zn
2+
bound as observed in the crystal is in an inhibited state due to the
displacement of the critical b3-b4-strand region now partially
blocking the active site. There are several lines of data that indicate
that in the absence of Zn
2+, RG13 adopts a much more
catalytically conducive conformation compared to the observed
Zn
2+ bound structure, even before maltose binding. First, previous
kinetic studies showed that in the presence of maltose, RG13 has
wt TEM-1 activity. Even when maltose is absent, there is still
significant activity present since the kcat/Km is ,25-fold lower
activity compared to wild-type TEM-1 with kcat and Km each only
improving roughly 3- and 8-fold, respectively, upon maltose
binding (Table 2). Note that if the b3-strand would be displaced
entirely in the presence (or absence) of maltose, the effect on
activity would be drastic as there would be no oxyanion hole, no
K234 and R244, and such an active site configuration would likely
therefore also have little or no catalytic activity. For example, the
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induced conformational changes. (A) Superpositioning of the subdomain 1 of MBP (residues 1–109 and 261–316) from maltose-free MBP (red,
PDBid 1OMP), maltotriose-bound MBP (green, PDBid 3MBP), and RG13 P1 space group structure (yellow). MBP anchor/fusion points labeled ‘19 (R316)
and ‘29 (A586(319)) to which TEM-1 is fused are labeled and colored as orange and red spheres, respectively. The respective MBP helices to which
these two MBP anchor points are adjacent to are helices a14 and a15, respecively. The positions of S585, introduced as part of constructing RG13
(Figure 1A), and the TEM-1 residues 228, 229, and 230 in the RG13 fusion protein are labeled; the other connecting TEM-1 residues are shown as
dashed grey lines. Shifts in the Ca positions of the a15 helix going from unbound to maltotriose bound MBP conformation are indicated by dashed
arrows. (B) Close-up view of RG13 fusion site showing the MBP (yellow) and TEM-1 domains (magenta) of RG13, and the modeled position of an intact
TEM-1 domain (blue, PDBid 1ERO which includes a boronic acid inhibitor to indicate the position of the active site). Modeling target points F318 (230)
and G584 (228) in RG13 are shown as a grey and magenta sphere, respectively, and the equivalent positions F230 and G228 in wt TEM-1 are depicted
as green spheres. The movement that is needed for G584 (228) in RG13 to reach the G228 position as found in wt TEM-1 is depicted by a dashed
arrow. The MBP anchor point helices a14 and a15, are shown in yellow helix cartoon representation. TEM-1 b3 and b4 strands are labeled; (C) zoomed
out view as in (B). TEM-1 bound boronic acid inhibitor (BAI) is shown in magenta stick representation to pinpoint the position of the TEM-1 active site.
The black line and small black helix depict the RG13 residues that normally form the TEM-1 b3 and part of b4 strand yet now form the linker between
the TEM-1 and MBP domains in the zinc inhibited RG13 structure. The rectangular dashed box in RG13 highlights the position of where the b3 strand
used to be in an intact TEM-1 conformation.
doi:10.1371/journal.pone.0039168.g005
Figure 6. Zinc ion regulation in RG13. (A) RG13 (yellow and magenta) is superimposed onto wt TEM-1 (in grey). The crystallographically observed
zinc binding ligands D164, H468, and E477 in RG13 are shown in ball-and-stick. Active site residues S70, E166, R244, and N276 are also shown. MBP is
depicted in yellow with its anchor/fusion point helices a14 and a15 shown as yellow transparent rods. TEM-1 is shown in magenta with its original N-
and C-terminal helices a1 and a12 shown in magenta transparent rods. The engineered GSGGG linker between these helices is shown in blue. The
position of the original TEM-1 b3 strand position is indicated by the transparent red strand. The linkers 1 and 2 between MBP and TEM-1 are labeled 1
and 2, respectively. The positions of the RG13 residues previously shown to be involved in the zinc-mediated inhibition of RG13, H375 and H382 (i.e.
TEM-1 residues 26 and 289), are shown in ball and stick and labeled. TEM-1 helix a10 is also labeled due to its close proximity to the active site, close
proximity to TEM-1 a12, and observed structural differences between RG13 and TEM-1. (B) Surface representation depicting the TEM-1 fusion site and
GSGGG-loop region of a modeled TEM-1 with an intact b3-b4 strand section and the GSGGG-loop within the RG13 framework. Depicted are residues
H26 and H289 from the original N- and C-terminal helices of TEM-1, respectively. Also shown are residues W290 and W229 as well as the residues 230
and 228. This surface is facing the MBP domain in RG13 revealing the potential steric and structural consequences of mutations in the histidine
residues.
doi:10.1371/journal.pone.0039168.g006
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and the K234A mutation in a related b-lactamase decreased kcat/
Km multiple orders of magnitude [16]. Second, in agreement that
aZ n
2+-free and maltose-bound RG13 structure likely adopts
a more catalytically proficient conformation is that a previous
NMR study found that, in the presence of maltose, the entire b3-
strand can be assigned to a wt position (even in the absence of
maltose, roughly two-thirds of the C-terminal part of the TEM-1
b3 strand in RG13 can be assigned to a relatively wt conformation
including K234) [8]. In conclusion, it seems therefore likely that in
maltose-bound RG13, the entire b3-strand is in the wt TEM-1
position. With the RG13 fusion sites between TEM-1 and MBP
being at the beginning of this b3 strand (i.e. residues 228 and 229),
and that this entire b3 strands adopts a wt-like position in RG13 in
the presence of maltose, according to the NMR study, yielded
a starting direction to model RG13 in a more activated state. This
was done via rigid body modeling an active wt TEM-1 structure
within an RG13 framework dictated by the fusion points (Figure 5).
The rigid body modeling indicated that juxtapositioning an intact
TEM-1 molecule adjacent to where it is fused to MBP in RG13
results in a very close distance between the two domains.
Furthermore, the fusion point distance between TEM-1 is only
moderately too large when MBP is in the unliganded conforma-
tion (Figure 5). However, this potential fusion distance mismatch is
likely shortened upon the extrapolated maltose-induced MBP
conformational changes (Figure 5A). This suggests that maltose
brings about a conformational change such that RG13 residues
G584 (G228) and F318(F230) can adopt a distance more closely
observed in wt TEM-1 for these corresponding residues G228 and
F230 thereby likely allowing a catalytic proficient conformation for
this entire region encompassing strands b3 and b4. In addition to
the fusion points juxtapositioning upon maltose binding, the MBP
surface near the fusion sites becomes less sterically repulsive as it
changes from concave to relatively flat upon maltose binding
(Figure 2B). As such, there will likely be less inter-domain steric
pull on the TEM-1 b3 fusion section by MBP when maltose is
bound.
Insights into the (Maltose Absent) apo RG13 Structure
There are three points of evidence that indicate that the N-
terminal half of the b3 strand of TEM-1 in RG13 in the absence of
maltose is in a more tensed, non-wt position. Firstly, this stretch of
residues could not be assigned to the wt TEM-1 position using
NMR measurements on RG13 in the absence of maltose but,
upon maltose binding, changes conformation and could be
assigned [8]. Second, the ease of dislodging the b3 strand, and
adjacent b4 strand region, by binding zinc at mM concentrations
at an interdomain site as evidenced in the RG13 crystal structures
suggests that some strain or partial displacement is already present
in this b3 region. Thirdly, the molecular modeling of an intact
TEM-1 within the RG13 framework indicated a very close
proximity between the TEM-1 and MBP domains since the fusion
points on either domain are not on protruding, flexible loop
regions. We therefore hypothesize that, in the absence of maltose
and zinc, that by MBP sterically pulling slightly on the TEM-1 b3-
strand, which starts at TEM-1 residue F230, this strand is modestly
shifted in maltose-free RG13 affecting both kcat (oxyanion needed)
and Km (carboxyl moiety interaction needed). Since the N-terminal
part of the b3 strand is very close to both K234 and A237 of
TEM-1 located in the middle of the b3 strand (even though these
two residues were assigned in the NMR spectra), subtle changes in
their dynamics and position could account for the 25-fold maltose-
dependent activity switching of RG13. A slight pulling on the N-
terminal end of the b3 by a maltose-free MBP domain in RG13
could affect the position of the important oxyanion hole, involving
A237, by perhaps 0.1–0.4A ˚ which will both have an effect on Km
and kcat (as the substrate needs to place its carbonyl oxygen in this
site and also it needs to be primed for ,2 steps during catalysis
(each only 5-fold so changes need to be small). Shifts of that
magnitude in the oxy-anion hole residues of a closely related b-
lactamase [17] have been observed to affect kcat in the 5-fold range
[18].
We note that TEM-1 residue E166 was previously suggested to
be functionally perturbed prior to maltose binding due to (a)
a decreased deacylation of RG13 in the absence of maltose and (b)
disappearance of the E166 peak in the NMR spectra of apo-RG13
(although this peak in the HSQC-TROSY of RG13 in the
presence of maltose was however already quite weak) [7,8].
Residue E166 has a key role in deacylation [19] and therefore
seem to be a candidate residue to be involved in maltose switching
in RG13 yet the structure found this residue to be ordered and
quite distant from the fusion site. We do however not rule out an
indirect effect on the conformation of E166 via b3 strand changes
as this strand interacts with the E166-containing V loop. Such b3-
strand mediated V-loop changes were speculated for the G238S
mutant of TEM-1 [20] and we also recently observed a large V
loop displacement in variants of a closely related b-lactamase [21]
(although such a large loop shift was not observed in RG13 by
NMR [8]).
MBP Fusion Site
Our mutagenesis studies indicate that proper anchoring of the
linkers to MBP, via R316, S585 and even A586, is critical to
transmit the maltose signal as altering these residues led to loss of
maltose-switching (Figure 4). The mutations involving these
residues likely caused these anchor regions to be no longer tightly
interacting with MBP such that MBP no longer can control the
activity of TEM-1 thereby explaining their abrogated maltose
switching. This maltose switching is likely done by a positional
change, as illustrated by the shift in anchor points (Figure 5A),
and/or by relieving steric clashes between the concave surface of
the MBP domain upon maltose binding (Figure 2B). Previously,
the MBP mutation A319T (RG13 residue A586) was also found
to cause a loss of maltose switching [7]. This mutation is adjacent
to the S585 linker anchor residue and, since there is no space to
accommodate the threonine, this mutation will likely lead to a shift
of these few residues thereby likely displacing S585 from its
anchoring role. In addition to stable anchor residues, linker length
was also critical for switching as introducing slack into linker 1 via
a glycine insertion led to loss of switching as the maltose-free
activity increased to wt TEM-1 activity. Furthermore, by de-
creasing slack in the linker 2 region, via deletion of G584, the
maltose-free activity could be further dampened and maltose
switching increased. Proper linker anchoring and linker length are
thus critical attributes for maltose switching by RG13.
In addition to RG13, another TEM-1 MBP fusion protein has
previously been obtained that uses the same MBP fusion site of
residue 316 to also obtain maltose-dependent signaling [2]. But
instead of TEM-1 residue 229 being fused to MBP residue 316,
this other MBP-TEM-1 construct fused TEM-1 residue N170 to
MBP residue 316. This suggests that this MBP region, near residue
316, has unique and robust features that can transmit maltose-
dependent conformational changes to an unrelated protein in
different ways. This other MBP-TEM-1 maltose-regulated fusion
construct was shown to have its maltose-dependent abilities to be
negatively affected by increasing the linker length by one and two
additional residues [2]. This agrees with our RG13 structure-based
allostery hypothesis as the linker length and amount of slack are
Structure of Beta-Lactamase MBP Fusion Protein
PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e39168hypothesized to be key for proper maltose signaling in RG13.
Another example indicating that short linkers tend to have better
switching properties in engineered allosteric fusion proteins is
a TEM-1:cytochrome b562 construct [22,23].
It is interesting as to why MBP residue 316 is selected for during
the generation of two different maltose-regulated TEM-1 fusion
constructs as residue 316 is not near where the largest
conformational differences are observed upon maltose binding
that include a 35u domain closure conformational change. Residue
316 is actually situated on the backside of the hinge region of the
bi-lobal MBP structure. However, one has to consider as to how
these allosteric fusion proteins are generated as the TEM-1
domain is inserted into a single site of MBP (with possibly some
residues deleted as in RG13, Figure 1). Although the linker anchor
points of MBP are not where there are the largest differences in
distance between an uncomplexed and complexed MBP are
found, the anchor points are near where the largest differences are
when one only considers Ca positions of a few residues
downstream from each other in the continuous polypeptide chain
to allow for insertion of the non-homologous TEM-1 gene at
a single site. By calculating Ca-CaD distance measurement of
residues i and i+x via substracting the distances from the maltose-
bound from the maltose-free MBP structure, the MBP region at
residue 312 lights up as to having the largest Ca-Ca difference for
i and i+3 and i and i+6 (Figure 7). These calculations suggest that
the MBP region from 312 to 312+i (i.e. 312–318) has the largest
shifts thereby likely explaining why insertions near residue 316, in
particular since R316 has adopted the linker anchor role in RG13
(Figure 2C), are capable of transmitting maltose signals to TEM-1
(as is also evident mechanistically in Figure 5A). An additional
potential benefit of this region, being on the backside of MBP, is
that this region could exert a lever/torque effect as the fusion
points are close to the hinge region. As such, this region is thus
perhaps able to exert a larger force on the movements near its
rotation point, which might be needed as the b3 TEM-1 strand is
normally well lodged into the active site. Furthermore, the
backside of MBP, near the hinge region where TEM-1 is attached,
changes from concave to more flat upon maltose binding
(Figure 2B) and could therefore decrease steric contacts between
TEM-1 and MBP and thus provide additional slack for the b3
linker regions such that they can adopt the wt catalytically
competent conformation. It is remarkable that the forced
evolutionary pressure resulted in this successful RG13 of having
indeed found the MBP 312–318 region and the 230 b3-strand
region of TEM-1 indicating that this approach works to find this
narrow signaling window region being almost a ‘needle in a hay
stack’.
Zn
2+ Binding and Regulation in RG13
Biochemical and mutagenesis studies indicated that Zn
2+
inhibits RG13 in a non-competitive, yet reversible manner and
suggested the presence of a single low mMZ n
2+ site with an
inhibitory role for residues H382 (H26) and H375 (H289) [6].
These residues likely have an indirect role as mutating these
residues did not affect Zn
2+ binding, only Zn
2+ inhibition. In
agreement, the structure of RG13 revealed also no direct
involvement of these histidine residues in Zn
2+ binding even with
mM Zn
2+ concentration. Instead, the RG13 structure, with
2.5 mM Zn
2+ present, revealed a Zn
2+ binding role and
potentially regulatory role for role for residues D164, H468 and
potentially E477. However, mutating 2 or 3 of these residues only
caused a minor effect (2- to 4-fold; Table 2) on the Ki for Zn
2+
indicating no exclusive role for D164/H468/E477 in the Zn
2+
inhibition mechanism. In agreement, previous mutagenesis studies
found that the H452A/H468L mutation pair did not alter Zn
2+’s
inhibitory effect [6]. The observed second Zn
2+ site, which also
involves residues from two neighboring crystallographically related
RG13 molecules (in the P1 space group), is likely also not
functionally relevant for RG13 as mutating H509 (H153) or H514
(H158) did not affect Zn
2+ inhibition [6].
There are three possible explanations for the apparent
discrepancy between the mutagenesis results and the crystallo-
graphically observed Zn
2+ binding site in RG13. First, Zn
2+
binding to RG13 could be kinetically controlled such that at early
time points, the lowest energy barrier binding site will be occupied
first whereas the energetically most favorable binding site might
take longer to reach due to a higher initial energy barrier. The
latter state could perhaps be reached during the several days it
took for RG13 crystals to form. This could be compounded by the
difference in ‘‘induced-fit’’ and ‘‘conformational selection’’ as
modes of binding [24]. At low concentrations, conformational
selection takes place, whereas at higher concentrations, induced fit
takes place (i.e. ligand binding first to low affinity conformation
thereby inducing conformational change). A second possibility is
that only the observed zinc-bound conformations could be
crystallized such that crystallization selected for a particular
conformation that might perhaps not be the dominant one in
solution. A third possible explanation is that there is more than
one low mM inhibitory zinc binding site that are all mutually
exclusive since they involve juxtapositioning of 1–2 liganding
residues of MBP and 1–2 liganding residues of TEM-1. This last
possibility is especially intriguing as previous mutagenesis experi-
ments, indirectly, indicated that the presumed single Zn
2+ binding
site in RG13 would fall into a rare category of Zn
2+ binding sites:
single and double mutant studies had ruled out all histidine and
cysteine residues in RG13 being involved in zinc binding [6] if the
hypothesis were correct regarding a single unique inhibitory Zn
2+
site. However, a Zn
2+ binding site without histidine and without
cysteine is quite rare as it has only been observed in ,1% out of
the over 230 different Zn
2+ sites [25]. Thus, if there is indeed
a single unique non-histidine/non-cysteine Zn
2+ inhibitory site in
RG13, it would fall into this rare category that could not even be
observed crystallographically at mM zinc concentrations in the
RG13 structures whereas two different, histidine-containing, Zn
2+
sites were observed instead. Therefore, an alternative interpreta-
tion is that RG13 has multiple, yet mutually exclusive low mM
inhibitory zinc binding sites that likely will have one or more
histidine liganding residues (cysteine residues are occupied in
disulfide bonds).
That there are multiple mutually exclusive mMZ n
2+ inhibitory
sites is an attractive hypothesis for two additional reasons. First,
RG13 has a potential mechanism to form multiple mutually
exclusive inhibitory Zn
2+ binding sites via mere rotation and
repositioning of the MBP and TEM-1 domains to juxtaposition 1–
2Z n
2+ liganding residues from each domain. Such juxtaposition-
ing could perhaps entail Zn
2+ first binding to one of the (histidine-
containing) multi-residue ‘‘half-sites’’ situated on one domain (i.e.
H468/E477, H509/H514, or Y17/H39; see Figure S2) followed
by 1–2 additional ligands from the other domain such as D164
combining with H468/E477 (Figure S2). Note that mMZ n
binding can be readily be engineered into a variety of proteins via
juxtapositioning of at least 2 His residues [26–29]. Due to avidity,
all RG13 would need to do is to rotate, and perhaps shift the two
domains somewhat such that His/Asp/Glu and/or other Zn
2+
liganding residues from the different domains are juxtaposed
locking the RG13 in a more fixed conformation thus affecting the
critical linker regions. As RG13 has a low pI of 5.53, it has ample
opportunity to do this via 40 Asp, 47 Glu, and 9 His residues such
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2+ (96 out
of 637 residues). Since most of these residues are at the surface, the
relative amount of potential Zn
2+ liganding residues is thus even
higher. We hypothesize that the multiple yet mutually exclusive
inhibitory Zn
2+ sites of RG13 share common features such as
bridging both TEM-1 and MBP and also affecting the critical
inter-domain linker regions. A second additional reason for the
multiple mutually exclusive Zn
2+ sites hypothesis is that it provides
an explanation for the mutagenesis results as the double and triple
mutant neither fully nor negligibly affected the Ki (2- to 4-fold
change was observed); these mutants likely thus eliminated one of
the inhibitory Zn
2+ sites from the population causing a partial
Zn
2+ binding site redistribution. Note that inter-domain Zn
2+
binding is the most likely possibility as MBP and TEM-1
themselves as individual proteins are not regulated by Zn
2+ [6].
Also, if the mMZ n
2+ binding site were located within just one of
the domains, some Zn
2+ electron density would have likely become
apparent due to the mM Zn
2+ concentration used during
crystallization. It is also not uncommon to have two mutually
exclusive zinc binding sites as this was observed previously in an
engineered zinc biosensor [30]. This third possibility to explain the
discrepancy between the mutagenesis data and the RG13 structure
would thus render the RG13:Zn
2+ crystal structure as one of the
two or more modes of Zn
2+ inhibition in RG13 with individual
Zn
2+ affinities such that the apparent Ki shifts by about 3-fold upon
mutating the crystallographically observed one (from 2mMt o4 –
8mM; Table 2). Future experiments are needed to further probe
these three possible explanations.
Regarding the indirect role of H382 (H26) and H375 (H289)i n
Zn
2+ inhibition [6], we hypothesize that the above noted close
steric proximity between the MBP and TEM-1 domains could
explain why mutating TEM-1 residues H26 and/or H289 had an
effect on Zn
2+ inhibition but not on Zn
2+ binding [6]. Each of
these histidines is at the end of a helix either after or before the
GSGGG loop. Their side chains both protrude to the solvent
forming an aromatic stacking interaction with each other
(Figure 6). We postulate that mutating either or both of these
histidines to alanine results not only in removal of a sterically
protruding histidine sidechain, but could also lead to a shift of the
other histidine concomitant with shift or disorder of this entire
engineered loop region comprising residues
H375W376GSGGGH382 (H375 is TEM-1 residue H289 and
Figure 7. Structure of uncomplexed MBP (1OMP) showing maltose-induced local Ca-Ca distance shifts. Maltose-dependent Ca-Ca
distance differences for residues i=i+3 and i=i+6 are averaged and mapped onto the structure with residues color ramped from blue to red for
averaged shifts ranging from 0 to 1.4A ˚, respectively. Residue 312 yielded the largest maltose-dependent local shifts (1.4A ˚). Labeled also are residues
315 (i+3) and 318 (i+6) with arrows to residue 312 (i) indicating the local distances that were maximally shifted by maltose. Helices a14 and a15 are
labeled as well as residue 316 (black), the site of the RG13’s TEM-1 insertion in MBP, to show that the insertion occurred within the maltose-
dependent locally shifting region of 312–318 situated between the two helices. Labeled residues are also shown as spheres. The orientation of MBP is
similar to that of Figure 5.
doi:10.1371/journal.pone.0039168.g007
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fusion site (Figure 6) and being potentially less protruding and less
ordered upon a HRA mutation could lessen the steric repulsion
between the MBP and TEM-1 domains in that region and thus
allow Zn
2+ to bind to the interdomain site(s) without having to
dislodge the b3-b4 region when the MBP and TEM-1 domains
pivot to juxtaposition Zn
2+ liganding residues. An alternative
explanation, but sharing similar features, is that the histidine
mutation(s) cause destabilization of the circularly-permutated loop
region that could alter the W376(W290)-W317(W229) interaction
(Figure 6B). These tryptophan residues in TEM-1 are not tolerant
to substitution [13]; W229 is near the fusion site (Figure 1) and is
displaced 25A ˚ in RG13 compared to its position in the wt TEM-1
structure. A H26A and/or H289A mutation could thus indirectly
disrupt the W229:W290 interaction thereby affecting whether the
critical b3-b4 region will be dislodged when inter-domain Zn
2+ is
bound.
Here we propose a mechanistic model for RG13 from the above
findings and discussion: The N-terminal section of the b3 strand
adjacent to the TEM-1 228 fusion point is likely strained or
partially displaced in RG13. This strain in the absence of maltose
is likely due to a combination of the close proximity of the TEM-1
and MBP domains when fused in RG13 that is exacerbated by the
concave character of that MBP domain surface and the increased
distance between the anchor points. This tensed state of the TEM-
1 domain can undergo two different allosteric pathways. First,
activation via relieving the strain by maltose binding will alleviate
the steric repulsion between the MBP and TEM-1 domains due to
flattening the surface near the MBP fusion site from its concave
state in the absence of maltose. Furthermore, maltose binding will
change the position of MBP helices a14 and a15 such as to shorten
the distance between the anchor points about 2A ˚. A second
pathway the strained apo-RG13 molecule could undertake is
inhibition via Zn
2+ mediated reorientation of the MBP and TEM-
1 domains by forming a 3
rd (Zn
2+-mediated) contact point between
these domains (in addition to the two linkers already present in
RG13). This would allow the strained b3 strand region to
completely pop out of its strained wt-type-like position as the inter-
domain bridging zinc ion ‘twist-ties’ the linkers to gain the needed
additional linker slack for Zn
2+ to bind to both domains (at
multiple yet mutually exclusive sites). The described findings
regarding maltose and Zn
2+ regulation in an engineered fusion
protein could be useful for future allosteric protein engineering
efforts.
Materials and Methods
Expression and Purification
RG13 was expressed and purified as previously described [6].
Briefly, the expression plasmid containing RG13 was transformed
into Escherichia coli strain PM9F’. The culture were inducted by
1 mM IPTG and grew overnight at 20uC. Cells were lysed by
French press and RG13 was subsequently purified using an
amylase affinity resin (New England Biolabs) and eluted using
maltose. The eluted RG13 protein was dialyzed at 4uC, to remove
maltose, and subsequently concentrated to ,11 mg/mL in
20 mM Tris-Cl pH7.0 before mixing with glycerol for storage at
280uC. Aliquots of RG13 were thawed and subjected to gel
filtration using a Superdex200 column (GE Biosciences) that was
equilibrated with 20 mM Tris/HCl pH 7.2 and 500 mM NaCl.
RG13 was subsequently buffer exchanged to 10 mM Tris/HCl
pH 7.2, and concentrated to 10–15 mg/ml, as assessed by the
Bradford assay, prior to crystallization. RG13 mutants were
expressed as above with the following exceptions. The strain used
was BL21, the overnight growth temperature was 25uC, and
purification was performed using an MBPTrap column (GE
Biosciences).
Crystallization and Soaking
Prior to crystallization, ZnCl2 was added to RG13 to a final
concentration of 2.5 mM. Initial crystallization conditions were
found by using Hampton screen kits. After optimization, single
crystals were obtained by vapor diffusion sitting drop method at
room temperature: a 1.0 ml drop was prepared using 0.5 ml protein
mixture (13.8 mg/ml RG13 and 2.5 mM ZnCl2) and 0.5 ml
reservoir solution (containing 0.2M Ammonium Acetate, 0.1M
Tris pH 8.5–9.5, 15–30% PEG3350) and equilibrated over a 1 ml
reservoir solution. RG13-Zn co-crystals grew to full size in one
week and were subsequently cryo-protected in the reservoir
solution with 33%PEG3350 and 2.5 mM ZnCl2.
Data Collection and Structure Determination
Crystals of RG13 grew in two different space groups.
Diffraction data for the RG13-Zn complex P1 and C2 spacegroup
crystals were collected at the National Synchrotron Light Source
X-29A and processed using HKL2000 [31,32]. The data from the
P1 space group was double checked but could not be processed in
a higher symmetry space group. The structures for each of the
space groups was solved by Molecular Replacement using the
program Phaser [33] with two RG13 molecules in the P1 space
group and one RG13 molecule in C2 space group. Based on the
folding pattern of MBP of having two subdomains and the circular
permutation of RG13 [5], molecular replacement searches were
carried out using search models encompassing each of the MBP
subdomains and most of the TEM-1 structure to search for the two
copies of RG13 molecules in the asymmetric unit of P1 space
group. The search models were obtained from the MBP structure
(PDBid 1OMP) and the TEM-1 structure (PDBid 1ZG4). The
Molecular Replacement program Phaser [33] successfully placed
the subdomains in the asymmetric unit of P1 and C2 space groups
to yield two and one RG13 molecules, respectively, in the
asymmetric unit. After several rounds of REFMAC (CCP4 suite
[34]) refinement and adjusted using COOT [10], most residues of
the full length RG13 protein in both space groups could be built.
During the refinement, inspection of Fourier difference maps
indicated the presence of very strong non-protein electron density
peaks which were identified, and refined subsequently, as zinc
ions. Water molecules were included in the final stages of
refinement. The simulated annealing protocol in CNS [35] was
also used in refinement. Iterative rebuilding and refinement
allowed the final model to converge with an R/Rfree 23.2/29.2%
for the P1 space group and 23.3/29.1% for the C2 space group
(Table 1 for more refinement stats). The C2 space group contains
RG13 residues 1–316, 328–582, 585–637, 2 zinc ions, and 134
water molecules whereas the P1 space group structure contains
two RG13 copies of residues 1–637, 4 zinc ions, and 490 water
molecules. PROCHECK [36] and DDQ [37] were used during
the model building process and to validate the final structures. The
atomic coordinates and structure factors of the RG13 with zinc
ions for the P1 and C2 space groups have been deposited in the
Protein Data Bank under accession code 4DXB and 4DXC,
respectively. For the rigid body positioning of an intact TEM-1
domain within a RG13 framework, we used the program COOT
and the coordinate files as described in the results section.
Biochemical Characterization of RG13 and RG13 Mutants
The Ki for Zn
2+ for was determined as previously described by
nitrocefin hydrolysis assay [6]. Maltose-induced switching was
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PLoS ONE | www.plosone.org 13 June 2012 | Volume 7 | Issue 6 | e39168determined at 25uC by nitrocefin hydrolysis assay with and
without maltose in which the initial rate of nitrocefin hydrolysis
was monitored at 486 nm as previously described [5]. Solution
conditions were 100 mM sodium phosphate buffer (pH 7.4) with
26 nM protein, 100 mM nitrocefin, and 0 or 10 mM maltose.
Supporting Information
Figure S1 Electron density for active site and linker regions of
RG13 (A) 2Fo-Fc density map depicting the TEM-1 active site
region; (B) 2Fo-Fc density maps for residues 315–330 (the linker 1
region) and (C) residues 571–587 (the linker 2 region); (D) 2Fo-Fc
density map for residues 377–381 (the engineered GSGGG linker);
(E) Temperature representation of the RG13 structure in the P1
space group. The thicker and the more red the backbone is, the
more flexible it is due to its higher refined temperature factors. All
density maps shown are contoured at 1.0s.
(TIF)
Figure S2 Zinc ion binding sites in RG13. (A) main zinc ion
RG13 binding site in space group C2 structure bridges MPB
domain and TEM domains of RG13 involving residues D164,
H468, and E477. (B) The main zinc ion binding site in space
group P1 involves residues D164 and H468; (C) Second zinc ion
binding site in the C2 space group structure involving residues of
H509 and H514 in the TEM domain of RG13. (D) The second
zinc binding site in the P1 space group involving H509, H514,
Y179, and H399 (the latter two belong to a crystallographically
related RG13-MBP domain). The 2Fo-Fc density maps were
contoured at 1.5s and colored blue for the amino acid residues of
RG13 and the water molecules. Omit Fo-Fc maps were contoured
at 10s and colored green for the Zn ions. Domain coloring is same
as in Figure 1 with the crystallographic related neighboring
molecules depicted in grey. Water molecules and zinc ions are
shown as red and grey spheres, respectively.
(TIF)
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